Atlas Trials

Phase I Study in RAD 001 Patients With Relapse AML

Clinical trial NCT01074086 · COMPLETED

Trial details

NCT number
NCT01074086
Sponsor
French Innovative Leukemia Organisation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AML
Start date
2008-02-01
Primary completion
2012-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.